These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23963829)

  • 1. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer.
    Uenosono Y; Arigami T; Kozono T; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirata M; Arima H; Funasako Y; Kijima Y; Nakajo A; Okumura H; Ishigami S; Hokita S; Ueno S; Natsugoe S
    Cancer; 2013 Nov; 119(22):3984-91. PubMed ID: 23963829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
    Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer.
    Cao W; Yang W; Li H; Lou G; Jiang J; Geng M; Xi W; Ren R; Qu Q; Jin X; Zhu Y; Jin Y
    J Surg Oncol; 2011 Feb; 103(2):110-5. PubMed ID: 21259243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
    Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
    Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.
    Komatsu S; Ichikawa D; Nishimura Y; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
    Anticancer Res; 2013 Apr; 33(4):1621-7. PubMed ID: 23564806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.
    Okabe H; Tsunoda S; Hosogi H; Hisamori S; Tanaka E; Tanaka S; Sakai Y
    Ann Surg Oncol; 2015 Nov; 22(12):3954-61. PubMed ID: 25777087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
    Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
    Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer.
    Zhang Q; Shan F; Li Z; Gao J; Li Y; Shen L; Ji J; Lu M
    J Transl Med; 2018 Jun; 16(1):171. PubMed ID: 29925382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
    Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
    Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
    Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
    Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating cancer cells after a gastrectomy for gastric cancer.
    Ikeguchi M; Kaibara N
    Surg Today; 2005; 35(6):436-41. PubMed ID: 15912289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
    Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
    Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic impact of circulating tumour cells in gastric cancer patients.
    Ito H; Sato J; Tsujino Y; Yamaguchi N; Kimura S; Gohda K; Murakami K; Onimaru M; Ohmori T; Ishikawa F; Inoue H
    World J Gastroenterol; 2016 Dec; 22(46):10232-10241. PubMed ID: 28028372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.